Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/vaccines9101056 http://scihub22266oqcxt.onion/10.3390/vaccines9101056 34696164!8538251!34696164     free     free     free       Vaccines+(Basel) 2021 ; 9 (10): ? Nephropedia Template TP {{tp|p=34696164|t=2021. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity |pdf=|usr=}}{{34696164}} gab.com Text SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity JO: Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=34696164 #FOAvip There is a lack of predictive markers for early and rapid identification of disease progression in COVID-19 patients. Our study aims at identifying microRNAs (miRNAs)/small nucleolar RNAs (snoRNAs) as potential biomarkers of COVID-19 severity. Using differential expression analysis of microarray data (n = 29), we identified hsa-miR-1246, ACA40, hsa-miR-4532, hsa-miR-145-5p, and ACA18 as the top five differentially expressed transcripts in severe versus asymptomatic, and ACA40, hsa-miR-3609, ENSG00000212378 (SNORD78), hsa-miR-1231, hsa-miR-885-3p as the most significant five in severe versus mild cases. Moreover, we found that white blood cell (WBC) count, absolute neutrophil count (ANC), neutrophil (%), lymphocyte (%), red blood cell (RBC) count, hemoglobin, hematocrit, D-Dimer, and albumin are significantly correlated with the identified differentially expressed miRNAs and snoRNAs. We report a unique miRNA and snoRNA profile that is associated with a higher risk of severity in a cohort of SARS-CoV-2 infected patients. Altogether, we present a differential expression analysis of COVID-19-associated microRNA (miRNA)/small nucleolar RNA (snoRNA) signature, highlighting their importance in SARS-CoV-2 infection. Twit Text FOAVip SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity ????Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=34696164 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34696164 #FOAvip English Wikipedia <ref>{{Cite pmid|34696164}}</ref> SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity #MMPMID34696164 Parray A; Mir FA; Doudin A; Iskandarani A; Danjuma MM; Kuni RAT; Abdelmajid A; Abdelhafez I; Arif R; Mulhim M; Abukhattab M; Dar SR; Moustafa AA; Elkord E; Al Khal AL; Elzouki AN; Cyprian F Vaccines (Basel) 2021[Sep]; 9 (10): ? PMID34696164show ga There is a lack of predictive markers for early and rapid identification of disease progression in COVID-19 patients. Our study aims at identifying microRNAs (miRNAs)/small nucleolar RNAs (snoRNAs) as potential biomarkers of COVID-19 severity. Using differential expression analysis of microarray data (n = 29), we identified hsa-miR-1246, ACA40, hsa-miR-4532, hsa-miR-145-5p, and ACA18 as the top five differentially expressed transcripts in severe versus asymptomatic, and ACA40, hsa-miR-3609, ENSG00000212378 (SNORD78), hsa-miR-1231, hsa-miR-885-3p as the most significant five in severe versus mild cases. Moreover, we found that white blood cell (WBC) count, absolute neutrophil count (ANC), neutrophil (%), lymphocyte (%), red blood cell (RBC) count, hemoglobin, hematocrit, D-Dimer, and albumin are significantly correlated with the identified differentially expressed miRNAs and snoRNAs. We report a unique miRNA and snoRNA profile that is associated with a higher risk of severity in a cohort of SARS-CoV-2 infected patients. Altogether, we present a differential expression analysis of COVID-19-associated microRNA (miRNA)/small nucleolar RNA (snoRNA) signature, highlighting their importance in SARS-CoV-2 infection. ?SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity (epmc).pdf DeepDyve Pubget Overpricing